| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.19 | 6e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.087 | 0.09 |